JP2021502391A5 - - Google Patents

Download PDF

Info

Publication number
JP2021502391A5
JP2021502391A5 JP2020526142A JP2020526142A JP2021502391A5 JP 2021502391 A5 JP2021502391 A5 JP 2021502391A5 JP 2020526142 A JP2020526142 A JP 2020526142A JP 2020526142 A JP2020526142 A JP 2020526142A JP 2021502391 A5 JP2021502391 A5 JP 2021502391A5
Authority
JP
Japan
Prior art keywords
composition
composition according
allergies
bacterial strains
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020526142A
Other languages
English (en)
Japanese (ja)
Other versions
JP7293220B2 (ja
JP2021502391A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/060187 external-priority patent/WO2019094837A1/en
Publication of JP2021502391A publication Critical patent/JP2021502391A/ja
Publication of JP2021502391A5 publication Critical patent/JP2021502391A5/ja
Priority to JP2023093879A priority Critical patent/JP2023121755A/ja
Application granted granted Critical
Publication of JP7293220B2 publication Critical patent/JP7293220B2/ja
Priority to JP2025105253A priority patent/JP2025170783A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020526142A 2017-11-09 2018-11-09 アレルギーの処置のための組成物および方法 Active JP7293220B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023093879A JP2023121755A (ja) 2017-11-09 2023-06-07 アレルギーの処置のための組成物および方法
JP2025105253A JP2025170783A (ja) 2017-11-09 2025-06-23 アレルギーの処置のための組成物および方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762583777P 2017-11-09 2017-11-09
US62/583,777 2017-11-09
US201862637355P 2018-03-01 2018-03-01
US62/637,355 2018-03-01
US201862721786P 2018-08-23 2018-08-23
US62/721,786 2018-08-23
PCT/US2018/060187 WO2019094837A1 (en) 2017-11-09 2018-11-09 Compositions and methods for the treatment of allergy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023093879A Division JP2023121755A (ja) 2017-11-09 2023-06-07 アレルギーの処置のための組成物および方法

Publications (3)

Publication Number Publication Date
JP2021502391A JP2021502391A (ja) 2021-01-28
JP2021502391A5 true JP2021502391A5 (https=) 2021-12-16
JP7293220B2 JP7293220B2 (ja) 2023-06-19

Family

ID=66438676

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020526142A Active JP7293220B2 (ja) 2017-11-09 2018-11-09 アレルギーの処置のための組成物および方法
JP2023093879A Pending JP2023121755A (ja) 2017-11-09 2023-06-07 アレルギーの処置のための組成物および方法
JP2025105253A Pending JP2025170783A (ja) 2017-11-09 2025-06-23 アレルギーの処置のための組成物および方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023093879A Pending JP2023121755A (ja) 2017-11-09 2023-06-07 アレルギーの処置のための組成物および方法
JP2025105253A Pending JP2025170783A (ja) 2017-11-09 2025-06-23 アレルギーの処置のための組成物および方法

Country Status (7)

Country Link
US (1) US12582679B2 (https=)
EP (1) EP3706767A4 (https=)
JP (3) JP7293220B2 (https=)
CN (1) CN111526882A (https=)
AU (1) AU2018365071B2 (https=)
CA (1) CA3081978A1 (https=)
WO (1) WO2019094837A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018365071B2 (en) 2017-11-09 2025-09-11 Vedanta Biosciences, Inc. Compositions and methods for the treatment of allergy
US12053495B2 (en) 2017-12-11 2024-08-06 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms
WO2021055352A1 (en) * 2019-09-16 2021-03-25 Vedanta Biosciences, Inc. Methods and compositions for preserving bacteria
CN117202919A (zh) 2021-02-18 2023-12-08 韦丹塔生物科学股份有限公司 用于抑制病原生物体的组合物和方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5164167B2 (ja) 2005-08-30 2013-03-13 ユニバーシティー オブ マイアミ 免疫調節性腫瘍壊死因子受容体２５（ｔｎｆｒ２５）のアゴニスト、アンタゴニスト及び免疫毒素
CN116942833A (zh) * 2011-12-01 2023-10-27 国立大学法人 东京大学 诱导调节性t细胞的增殖或积累的人源细菌
US8906668B2 (en) * 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
JP6617935B2 (ja) * 2014-04-10 2019-12-11 国立研究開発法人理化学研究所 Ｔｈ１７細胞の誘導のための組成物及び方法
CN115252650A (zh) * 2015-11-03 2022-11-01 布里格姆及妇女医院股份有限公司 用于治疗和/或预防食物变态反应的治疗性微生物群
US11260083B2 (en) * 2016-03-15 2022-03-01 The Regents Of The University Of Michigan Compositions and methods for treating and preventing graft versus host disease
JP7168558B2 (ja) * 2016-06-14 2022-11-09 ヴェダンタ バイオサイエンシーズ インコーポレーテッド Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ感染症の処置
US9999641B2 (en) * 2016-06-14 2018-06-19 Vedanta Biosciences, Inc. Treatment of clostridium difficile infection
CA3211208A1 (en) * 2017-04-03 2018-10-11 Gusto Global, Llc Rational design of microbial-based biotherapeutics
US10507221B2 (en) * 2017-11-09 2019-12-17 Vedanta Biosciences, Inc. Compositions and methods for the treatment of allergy
AU2018365071B2 (en) 2017-11-09 2025-09-11 Vedanta Biosciences, Inc. Compositions and methods for the treatment of allergy
WO2021030198A1 (en) * 2019-08-09 2021-02-18 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms

Similar Documents

Publication Publication Date Title
US10844443B2 (en) Lactobacillus plantarum and composition comprising the same
EP2522358B1 (en) Peptides against rotavirus infection
CN102292431B (zh) 一种植物乳杆菌及含该植物乳杆菌的组合物
JP2021502391A5 (https=)
CN113906129A (zh) 嗜黏蛋白阿克曼菌eb-amdk19菌株及其用途
JP2023121755A5 (https=)
JP2013529087A5 (https=)
CN106413724B (zh) 与多糖聚合物粘合剂缀合的鼠李糖乳杆菌rht-3201及其用途
Hong et al. Different immune regulatory potential of Lactobacillus plantarum and Lactobacillus sakei isolated from kimchi
CN106795482B (zh) 允许在营养不良的情况下促进人和动物的幼年生长的乳杆菌组合物
Ali et al. Heat-killed Limosilactobacillus reuteri PSC102 ameliorates impaired immunity in cyclophosphamide-induced immunosuppressed mice
US10603377B2 (en) Method for enhancing generation of antigen-specific cytotoxic T lymphocytes (CTL) and antibodies
Giri et al. Effects of intracellular products of Bacillus subtilis VSG1 and Lactobacillus plantarum VSG3 on cytokine responses in the head kidney macrophages of Labeo rohita
Lazarenko et al. Imunobiotics are the novel biotech drugs with antibacterial and immunomodulatory properties
Soltani et al. Probiotic, paraprobiotic, and postbiotic as an alternative to antibiotic therapy for lactococcosis in aquaculture
Siddique et al. The Immunomodulatory Role
KR101898138B1 (ko) 면역 조절 t 세포를 유도하는 락토코커스 락티스 bfe920 균주를 포함하는 수산양식 기능성 사료 첨가제
KR20180112257A (ko) 어류의 에드워드병 예방 또는 치료용 약학 조성물, 및 어류의 에드워드병 예방 및 치료 방법
JP2022025973A (ja) 紅藻類を含む免疫賦活剤
Wong et al. Potential biocontrol for bacterial and viral disease treatment in aquaculture: a minireview
Rabetafika et al. Probiotics as Antibiotic Alternatives for Human and Animal Applications. Encyclopedia 2023, 3, 561–581
Kamilya et al. Probiotics as Vaccine Adjuvants
Qi et al. Effect of oral administration of Lactobacillus acidophilus on the intestinal mucosal immune cells in young bactrian camels (Camelus bactrianus)
TWI648059B (zh) 龍葵發酵產物於製備具增加免疫力功效的組合物之用途
Zhao et al. Research Advances in the Immunomodulatory Mechanisms of Probiotics on Non-Specific and Specific Immunity